What follow-up strategies should I implement for patients diagnosed with neuroendocrine tumours after initial treatment?

Follow-up strategies for patients diagnosed with neuroendocrine tumours after initial treatment should include:

• Regular clinical assessment to monitor for disease recurrence or progression.

• Personalised follow-up plans based on individual risk factors, tumour grade, and treatment received.

• Use of appropriate imaging modalities at scheduled intervals to detect recurrence or metastases, tailored to tumour behaviour and patient factors.

• Assessment and management of late effects of treatment, including endocrine dysfunction, neuropathy, or secondary tumours, with relevant specialist referrals as needed.

• Provision of a written treatment summary to the patient and their primary care team, outlining risks of late effects and follow-up plans.

• Encouragement of healthy lifestyle measures to reduce risks of complications such as stroke or secondary malignancies.

• Access to psychosocial support and rehabilitation services to address quality of life and functional needs.

While specific neuroendocrine tumour follow-up guidelines are not detailed in the provided context, these principles align with UK NICE recommendations for follow-up of brain tumours and other cancers, emphasising personalised surveillance, management of late effects, and multidisciplinary care coordination ¹,³.